These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 19043358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat.
    Zhang TT, Cui B, Dai DZ.
    Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F.
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [Abstract] [Full Text] [Related]

  • 6. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat.
    Lamberts RR, Vaessen RJ, Westerhof N, Stienen GJ.
    Basic Res Cardiol; 2007 Jan; 102(1):19-27. PubMed ID: 16944361
    [Abstract] [Full Text] [Related]

  • 7. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expression of GATA6 gene in lung tissue of rat with pulmonary hypertension].
    Liu B, Liu HM, Yu L, Sun XJ, Wei L, Wang XM, Zhou TF.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov 01; 37(6):864-7, 875. PubMed ID: 17236581
    [Abstract] [Full Text] [Related]

  • 10. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
    Correia-Pinto J, Henriques-Coelho T, Roncon-Albuquerque R, Lourenço AP, Melo-Rocha G, Vasques-Nóvoa F, Gillebert TC, Leite-Moreira AF.
    Basic Res Cardiol; 2009 Sep 01; 104(5):535-45. PubMed ID: 19288153
    [Abstract] [Full Text] [Related]

  • 11. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats.
    Jin HF, Du SX, Zhao X, Wei HL, Wang YF, Liang YF, Tang CS, Du JB.
    Acta Pharmacol Sin; 2008 Oct 01; 29(10):1157-66. PubMed ID: 18817619
    [Abstract] [Full Text] [Related]

  • 12. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC, Wilson DW, Lamé MW, Jones AD, Segall HJ.
    Toxicol Appl Pharmacol; 1993 Jan 01; 118(1):87-97. PubMed ID: 8430429
    [Abstract] [Full Text] [Related]

  • 13. Mechanical load-dependent regulation of gene expression in monocrotaline-induced right ventricular hypertrophy in the rat.
    Kögler H, Hartmann O, Leineweber K, Nguyen van P, Schott P, Brodde OE, Hasenfuss G.
    Circ Res; 2003 Aug 08; 93(3):230-7. PubMed ID: 12842921
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S, Kadowitz PJ, Thammasitboon S, Lasky JA, Hellstrom WJ.
    J Androl; 2009 Aug 08; 30(5):495-504. PubMed ID: 19201699
    [Abstract] [Full Text] [Related]

  • 16. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S, Tanita T, Ashino Y, Noda M, Tabata S, Hoshikawa Y, Ueda S, Nishimura T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May 08; 32(5):441-5. PubMed ID: 8084100
    [Abstract] [Full Text] [Related]

  • 17. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
    Angelini A, Castellani C, Ravara B, Franzin C, Pozzobon M, Tavano R, Libera LD, Papini E, Vettor R, De Coppi P, Thiene G, Vescovo G.
    J Heart Lung Transplant; 2011 Nov 08; 30(11):1281-93. PubMed ID: 21989772
    [Abstract] [Full Text] [Related]

  • 18. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B, Cheng YS, Dai DZ, Li N, Zhang TT, Dai Y.
    Clin Exp Pharmacol Physiol; 2009 Feb 08; 36(2):169-75. PubMed ID: 18986320
    [Abstract] [Full Text] [Related]

  • 19. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q, Chen Y, Chen X, Zhang J, Lu W, Wang J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May 08; 37(5):360-4. PubMed ID: 25011512
    [Abstract] [Full Text] [Related]

  • 20. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S, Horimoto H, Mieno S, Kishida K, Watanabe F, Furuya E, Katsumata T.
    Circulation; 2006 Jul 04; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.